Celldex Therapeutics ($CLDX) Insider Trading & Smart Money Activity
Celldex Therapeutics, Inc. ($CLDX) has 11 insider trades and 3 analyst ratings on file. Insiders filed 11 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 3
CLDX insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All CLDX insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Denice Torres | Buy (Grant or award) | 26K sh | +12.6% | +4.6% | — | |||||
| Insider | Ronald PepinSR. VP & CBO | Buy (Grant or award) | 20K sh | +12.6% | +4.6% | — | |||||
| Insider | Penner Harry JR | Buy (Grant or award) | 26K sh | +12.6% | +4.6% | Read | |||||
| Insider | Neil Garry Arthur | Buy (Grant or award) | 26K sh | +12.6% | +4.6% | Read | |||||
| Insider | Anthony MarucciPRESIDENT & CEO | Buy (Grant or award) | 375K sh | +12.6% | +4.6% | Read | |||||
| Insider | Martin Samuel BatesSVP AND CFO | Buy (Grant or award) | 93K sh | +12.6% | +4.6% | Read | |||||
| Insider | Tibor KelerEXECUTIVE VP & CSO | Buy (Grant or award) | 115K sh | +12.6% | +4.6% | Read | |||||
| Insider | Freddy JimenezSVP & GENERAL COUNSEL | Buy (Grant or award) | 93K sh | +12.6% | +4.6% | Read | |||||
| Insider | Margo Heath-ChiozziSVP OF REGULATORY AFFAIRS | Buy (Grant or award) | 95K sh | +12.6% | +4.6% | Read | |||||
| Insider | Herbert Conrad | Buy (Grant or award) | 26K sh | +12.6% | +4.6% | Read | |||||
| Insider | Sarah CavanaughSVP OF CORP AFFAIRS & ADMIN. | Buy (Grant or award) | 95K sh | +12.6% | +4.6% | Read | |||||
| Analyst | HC Wainwright | Reiterates to buy | PT $42 | +4.0% | +19.3% | Read | |||||
| Analyst | UBS | Reiterates to buy | PT $45 | +12.2% | +33.3% | — | |||||
| Analyst | UBS | Reiterates to buy | PT $45 | +12.2% | +33.3% | Read |
1W / 1M / 6M = how CLDX moved from the trade or filing date.
Insider trading in CLDX: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Denice Torres | 1 | — | Jun 25, 2026 | ||
| Ronald Pepin | SR. VP & CBO | 1 | — | Jun 25, 2026 | |
| Penner Harry JR | 1 | — | Jun 25, 2026 | ||
| Neil Garry Arthur | 1 | — | Jun 25, 2026 | ||
| Anthony Marucci | PRESIDENT & CEO | 1 | — | Jun 25, 2026 | |
| Martin Samuel Bates | SVP AND CFO | 1 | — | Jun 25, 2026 | |
| Tibor Keler | EXECUTIVE VP & CSO | 1 | — | Jun 25, 2026 | |
| Freddy Jimenez | SVP & GENERAL COUNSEL | 1 | — | Jun 25, 2026 | |
| Margo Heath-Chiozzi | SVP OF REGULATORY AFFAIRS | 1 | — | Jun 25, 2026 | |
| Herbert Conrad | 1 | — | Jun 25, 2026 | ||
| Sarah Cavanaugh | SVP OF CORP AFFAIRS & ADMIN. | 1 | — | Jun 25, 2026 |
Analyst ratings on CLDX
Frequently asked questions
What is the latest insider trade in CLDX?
Denice Torres filed a buy (grant or award) of 26K sh on Jun 25, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.